These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35645805)

  • 121. Introducing a pyrazolopyrimidine as a multi-tyrosine kinase inhibitor, using multi-QSAR and docking methods.
    Bahmani A; Tanzadehpanah H; Hosseinpour Moghadam N; Saidijam M
    Mol Divers; 2021 May; 25(2):949-965. PubMed ID: 32297121
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy.
    Liu J; Liu Y; Lin Y; Liang J
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):215-225. PubMed ID: 31565873
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
    Ferlay J; Colombet M; Soerjomataram I; Mathers C; Parkin DM; Piñeros M; Znaor A; Bray F
    Int J Cancer; 2019 Apr; 144(8):1941-1953. PubMed ID: 30350310
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
    CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Dose- and time-dependent pharmacokinetics of apigenin trimethyl ether.
    Elhennawy MG; Lin HS
    Eur J Pharm Sci; 2018 Jun; 118():96-102. PubMed ID: 29574080
    [TBL] [Abstract][Full Text] [Related]  

  • 126. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
    Roskoski R
    Pharmacol Res; 2018 Mar; 129():65-83. PubMed ID: 29408302
    [TBL] [Abstract][Full Text] [Related]  

  • 127. A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.
    Chow LQ; Santana-Davila R; Pantel A; Roth M; Anderson LN; Failor A; Doot R; Mankoff D
    PLoS One; 2017; 12(6):e0178325. PubMed ID: 28662033
    [TBL] [Abstract][Full Text] [Related]  

  • 128. PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer.
    Lopez-Campistrous A; Adewuyi EE; Benesch MGK; Ko YM; Lai R; Thiesen A; Dewald J; Wang P; Chu K; Ghosh S; Williams DC; Vos LJ; Brindley DN; McMullen TPW
    EBioMedicine; 2016 Oct; 12():86-97. PubMed ID: 27682510
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.
    Nagarajah J; Le M; Knauf JA; Ferrandino G; Montero-Conde C; Pillarsetty N; Bolaender A; Irwin C; Krishnamoorthy GP; Saqcena M; Larson SM; Ho AL; Seshan V; Ishii N; Carrasco N; Rosen N; Weber WA; Fagin JA
    J Clin Invest; 2016 Nov; 126(11):4119-4124. PubMed ID: 27669459
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.
    Hardin H; Yu XM; Harrison AD; Larrain C; Zhang R; Chen J; Chen H; Lloyd RV
    Am J Pathol; 2016 Jun; 186(6):1662-73. PubMed ID: 27060227
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
    Schlumberger M; Tahara M; Wirth LJ; Robinson B; Brose MS; Elisei R; Habra MA; Newbold K; Shah MH; Hoff AO; Gianoukakis AG; Kiyota N; Taylor MH; Kim SB; Krzyzanowska MK; Dutcus CE; de las Heras B; Zhu J; Sherman SI
    N Engl J Med; 2015 Feb; 372(7):621-30. PubMed ID: 25671254
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
    Brose MS; Nutting CM; Jarzab B; Elisei R; Siena S; Bastholt L; de la Fouchardiere C; Pacini F; Paschke R; Shong YK; Sherman SI; Smit JW; Chung J; Kappeler C; Peña C; Molnár I; Schlumberger MJ;
    Lancet; 2014 Jul; 384(9940):319-28. PubMed ID: 24768112
    [TBL] [Abstract][Full Text] [Related]  

  • 134. The O-methylation of chrysin markedly improves its intestinal anti-inflammatory properties: Structure-activity relationships of flavones.
    During A; Larondelle Y
    Biochem Pharmacol; 2013 Dec; 86(12):1739-46. PubMed ID: 24134915
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Structural and functional properties of platelet-derived growth factor and stem cell factor receptors.
    Heldin CH; Lennartsson J
    Cold Spring Harb Perspect Biol; 2013 Aug; 5(8):a009100. PubMed ID: 23906712
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay.
    Martinez Molina D; Jafari R; Ignatushchenko M; Seki T; Larsson EA; Dan C; Sreekumar L; Cao Y; Nordlund P
    Science; 2013 Jul; 341(6141):84-7. PubMed ID: 23828940
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.
    Yu XM; Jaskula-Sztul R; Ahmed K; Harrison AD; Kunnimalaiyaan M; Chen H
    Mol Cancer Ther; 2013 Jul; 12(7):1276-87. PubMed ID: 23594881
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Clinical, safety, and economic evidence in radioactive iodine-refractory differentiated thyroid cancer: a systematic literature review.
    Anderson RT; Linnehan JE; Tongbram V; Keating K; Wirth LJ
    Thyroid; 2013 Apr; 23(4):392-407. PubMed ID: 23294230
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Pharmacokinetics, bioavailability, tissue distribution, excretion, and metabolite identification of methoxyflavones in Kaempferia parviflora extract in rats.
    Mekjaruskul C; Jay M; Sripanidkulchai B
    Drug Metab Dispos; 2012 Dec; 40(12):2342-53. PubMed ID: 22961680
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.
    Liu YY; Zhang X; Ringel MD; Jhiang SM
    Endocr Relat Cancer; 2012 Jun; 19(3):291-304. PubMed ID: 22355179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.